Literature DB >> 8408181

Why does a higher response rate to chemotherapy correlate poorly with improved survival?

M Markman.   

Abstract

Mesh：

Year:  1993        PMID： 8408181     DOI： 10.1007/bf01195339

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  8 in total

1.  A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer.

Authors:  R Cellerino; D Tummarello; F Guidi; P Isidori; M Raspugli; B Biscottini; G Fatati
Journal:  J Clin Oncol       Date:  1991-08       Impact factor: 44.544

2.  Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

Authors:  P A Ganz; R A Figlin; C M Haskell; N La Soto; J Siau
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

3.  Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.

Authors:  J H Doroshow; P Multhauf; L Leong; K Margolin; T Litchfield; S Akman; B Carr; M Bertrand; D Goldberg; D Blayney
Journal:  J Clin Oncol       Date:  1990-03       Impact factor: 44.544

4.  Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer.

Authors:  N Kemeny; K Israel; D Niedzwiecki; D Chapman; J Botet; B Minsky; V Vinciguerra; R Rosenbluth; B Bosselli; C Cochran
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

5.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

6.  Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatment.

Authors:  R Cellerino; D Tummarello; E Porfiri; F Guidi; P Isidori; M Raspugli; B Biscottini; G Fatati
Journal:  Eur J Cancer Clin Oncol       Date:  1988-12

7.  Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

Authors:  E Rapp; J L Pater; A Willan; Y Cormier; N Murray; W K Evans; D I Hodson; D A Clark; R Feld; A M Arnold
Journal:  J Clin Oncol       Date:  1988-04       Impact factor: 44.544

8.  A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer.

Authors:  R L Woods; C J Williams; J Levi; J Page; D Bell; M Byrne; Z L Kerestes
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.